Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Tailored Therapy for Hodgkin Lymphoma Using Early Interim Therapy PET for Therapy Decision. [Phase 2]
Phase 2 trial evaluating tailored Hodgkin lymphoma therapy guided by early interim PET to inform treatment decisions, with the study status …
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant [Phase 2]
Phase 2 study evaluating plerixafor to rescue poor mobilizers in autologous stem cell transplantation has completed; results were posted in …
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia [Phase 1]
Phase 1 trial evaluating obatoclax mesylate in combination with vincristine, doxorubicin, and dexrazoxane in pediatric patients with relapse…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Safety Study of XmAb®2513 to Treat Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma [Phase 1]
A Phase 1 safety trial evaluating XmAb2513 for Hodgkin lymphoma and Anaplastic Large Cell Lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease [Phase 2]
A Phase 2 trial of Bryostatin-1 for Hodgkin lymphoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy [Phase 2]
Phase 2 trial evaluating bortezomib, ifosfamide, and vinorelbine for recurrent or refractory Hodgkin lymphoma in both adult and pediatric pa…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma [Phase 1, Phase 2]
This clinical trial update reports on the safety and tolerability results of PCI-24781 in patients with lymphoma, including Hodgkin lymphoma…
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies [Phase 2]
Phase 2 clinical trial evaluating T-cell depleted allogeneic stem cell transplantation for hematologic malignancies; study is completed with…
-
CLINICAL_TRIALS trial_result · 2014-03-21Clinical Trial Update: Proton Therapy for Hodgkin Lymphoma [NA]
The clinical trial NCT00850200 evaluating proton therapy for Hodgkin Lymphoma has completed and results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy [Phase 1]
A National Cancer Institute-sponsored Phase 1 trial evaluating sunitinib malate in HIV-positive cancer patients on antiretroviral therapy ha…
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat [Phase 1]
This is a Phase 1b trial update of AMG 655 in combination with bortezomib or vorinostat for lymphomas, including Hodgkin lymphoma and variou…
-
CLINICAL_TRIALS trial_result · 2014-02-26Clinical Trial Update: Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease [Phase 2]
Phase 2 trial evaluating the combination of chemotherapy and radiation therapy in children with previously untreated Hodgkin lymphoma stages…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 trial evaluating the combination of tanespimycin and bortezomib in adults with advanced solid tumors or lymphomas; the study was ter…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: TARC After alloSCT in Hodgkin's Lymphoma
This clinical trial update notes the completion of a study evaluating TARC levels after allogeneic stem cell transplantation in patients wit…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM). [Phase 2]
A Phase 2 trial evaluated the safety and efficacy of adding AMD3100 to a G-CSF mobilization regimen in patients with non-Hodgkin lymphoma, H…
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: Resminostat (4SC-201) in Relapsed or Refractory Hodgkin's Lymphoma [Phase 2]
Update on a Phase 2 trial of resminostat (4SC-201) in relapsed or refractory Hodgkin lymphoma. The study has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma [Phase 1]
This is a Phase 1 clinical trial evaluating allogeneic Epstein-Barr Virus-specific cytotoxic T-lymphocytes in patients with progressive, rel…
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells [Phase 3]
Phase 3 trial evaluating whether prophylactic moxifloxacin after high-dose chemotherapy with peripheral stem cell transplantation reduces ba…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease [Phase 3]
A Phase 3 trial of combination chemotherapy for advanced Hodgkin lymphoma has completed; the document notes the trial status but does not pr…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match [Phase 2]
Phase 2 trial evaluating pooled unrelated donor umbilical cord blood transplant for hematologic malignancies requiring allogeneic stem cell …
-
CLINICAL_TRIALS trial_result · 2013-11-18Clinical Trial Update: Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation [Phase 1, Phase 2]
This clinical trial update covers ASC-101 in patients with hematologic malignancies undergoing dual-cord umbilical cord blood transplantatio…
-
CLINICAL_TRIALS trial_result · 2013-11-18Clinical Trial Update: Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma [Phase 1]
A Phase 1 study of MLN4924 (pevonedistat), a Nedd8-activating enzyme inhibitor, in adults with lymphoma or multiple myeloma has been complet…
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma [Phase 2, Phase 3]
Phase 2/Phase 3 trial evaluating cyclosporine, interferon gamma, and interleukin-2 after high-dose myeloablative chemotherapy with autologou…
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection [Phase 2]
This clinical trial update covers a Phase 2 study evaluating combination chemotherapy for Hodgkin lymphoma in patients with HIV infection.
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma [Phase 3]
Phase 3 clinical trial update evaluating combination chemotherapy followed by peripheral stem cell transplant in patients with relapsed Hodg…